Email ID
Password
Scrip   
TorreyPines and Raptor to merge
30 July 2009
Sita Shah

TorreyPines Therapeutics and Raptor Pharmaceuticals are to merge, with Raptor shareholders owning 95% of the combined company and TorreyPines shareholders the remaining 5%.

The merged company, which will trade on Nasdaq through TorreyPines' existing listing, will be named Raptor Pharmaceuticals...



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36